Physician profile
Mohammad E Hoque
NPI 1093811341
$2,586.28
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $1,056 · 2021: $327 · 2022: $18.37 · 2024: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $709.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $989.27 | 2020 | |
| Penumbra, INC. | $709.52 | 2024 | Indigo System |
| Medtronic USA, INC. | $275.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $233.50 | 2019-2021 | |
| Abbvie INC. | $215.01 | 2019-2021 | |
| Braintree Laboratories, INC. | $73.31 | 2021 | |
| Alfasigma USA, INC. | $27.26 | 2020 | |
| Celgene Corporation | $25.14 | 2021 | |
| Janssen Biotech, INC. | $19.08 | 2021 | |
| Digestive Care, INC. | $18.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hoque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.